Literature DB >> 20721574

The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Pietro Balbi1, Silvana Salvini, Cira Fundarò, Giuseppe Frazzitta, Roberto Maestri, Dibo Mosah, Carla Uggetti, GianPietro Sechi.   

Abstract

Following the discovery of glial fibrillary acidic protein (GFAP) mutations as the causative factor of Alexander disease (AxD), new case reports have recently increased, prompting a more detailed comprehension of the clinical features of the three disease subtypes (infantile, juvenile and adult). While the clinical pattern of the infantile form has been substantially confirmed, the late-onset subtypes (i.e., juvenile and adult), once considered rare manifestations of AxD, have displayed a wider clinical spectrum. Our aim was to evaluate the clinical phenotype of the adult and juvenile forms by reviewing the previously reported cases. Data were collected from previously published reports on 112 subjects affected by neuropathologically or genetically proven adult and juvenile Alexander disease. Although the late-onset forms of AxD show a wide clinical variability, a common pattern emerges from comparing previously reported cases, characterized by pseudo-bulbar signs, ataxia, and spasticity, associated with atrophy of the medulla and upper cervical cord on neuroimaging. Late-onset AxD cases can no longer be considered as rare manifestations of the disease. The clinical pattern usually reflects the topographic localization of the lesions, with adult cases displaying a predominant infratentorial localization of the lesions. Juvenile cases show clinical and radiological features which are intermediate between adult and infantile forms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20721574     DOI: 10.1007/s00415-010-5706-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Alexander disease: GFAP mutations unify young and old.

Authors:  Albee Messing; Michael Brenner
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

2.  Central pontine myelinolysis and Rosenthal fibers of the brainstem. Association with emaciation and prolonged intravenous hyperalimentation.

Authors:  W S Tihen
Journal:  Neurology       Date:  1972-07       Impact factor: 9.910

3.  [Progressive neurogenic muscular atrophy in neuroaxonal dystrophy with Rosenthal fibers].

Authors:  G Ule
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

4.  Alexander's disease in an adult (leukodystrophy with Rosenthal fibers).

Authors: 
Journal:  Mo Med       Date:  1972-05

5.  Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord.

Authors:  M S van der Knaap; V Ramesh; R Schiffmann; S Blaser; M Kyllerman; A Gholkar; D W Ellison; J P van der Voorn; S J M van Dooren; C Jakobs; F Barkhof; G S Salomons
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

6.  A case of adult-onset Alexander disease with Arg416Trp human glial fibrillary acidic protein gene mutation.

Authors:  Takashi Kinoshita; Toshihiro Imaizumi; Yumiko Miura; Hiroshi Fujimoto; Mitsuyoshi Ayabe; Hiroshi Shoji; Yuji Okamoto; Hiroshi Takashima; Mitsuhiro Osame; Masanori Nakagawa
Journal:  Neurosci Lett       Date:  2003-10-30       Impact factor: 3.046

7.  Identification of GFAP gene mutation in hereditary adult-onset Alexander's disease.

Authors:  Michito Namekawa; Yoshihisa Takiyama; Yoko Aoki; Norio Takayashiki; Kumi Sakoe; Haruo Shimazaki; Tomohiro Taguchi; Yasufumi Tanaka; Masatoyo Nishizawa; Ken Saito; Yoichi Matsubara; Imaharu Nakano
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

8.  A novel GFAP mutation and disseminated white matter lesions: adult Alexander disease?

Authors:  Knut Brockmann; Moritz Meins; Angelika Taubert; Ralf Trappe; Martin Grond; Folker Hanefeld
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

Review 9.  The clinicopathological spectrum of Rosenthal fibre encephalopathy and Alexander's disease: a case report and review of the literature.

Authors:  J Jacob; N J Robertson; D A Hilton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

10.  Rosenthal fibers formation in the central nervous system. Its relation to Alexander's disease.

Authors:  D Soffer; D S Horoupian
Journal:  Acta Neuropathol       Date:  1979-06-15       Impact factor: 17.088

View more
  19 in total

1.  Adult-onset Alexander disease with an R66Q mutation in GFAP presented with severe vocal cord paralysis during sleep.

Authors:  Ayumi Hida; Hiroyuki Ishiura; Noritoshi Arai; Hisayo Fukuoka; Kanehiro Hasuo; Jun Goto; Yoshikazu Uesaka; Shoji Tsuji; Sousuke Takeuchi
Journal:  J Neurol       Date:  2012-05-23       Impact factor: 4.849

Review 2.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

Review 3.  Clinical neurogenetics: recent advances.

Authors:  Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2012-07-21       Impact factor: 4.849

4.  Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up.

Authors:  GianPietro Sechi; Isabella Ceccherini; Tiziana Bachetti; Giovanni A Deiana; Elia Sechi; Pietro Balbi
Journal:  JIMD Rep       Date:  2012-10-13

5.  Archetypal and new families with Alexander disease and novel mutations in GFAP.

Authors:  Albee Messing; Rong Li; Sakkubai Naidu; J Paul Taylor; Lital Silverman; Daniel Flint; Marjo S van der Knaap; Michael Brenner
Journal:  Arch Neurol       Date:  2011-10-10

6.  Neurobehavioral characterization of adult-onset Alexander disease: A family study.

Authors:  Maya L Lichtenstein; Emily Dwosh; Anupama Roy Chowdhury; Matthew J Farrer; Marna B McKenzie; Ilaria Guella; Daniel M Evans; Haakon B Nygaard; Jason R Shewchuk; Sherri Hayden; Jason J S Barton; Howard H Feldman
Journal:  Neurol Clin Pract       Date:  2017-10

7.  Late-onset Alexander disease with a V87L mutation in glial fibrillary acidic protein (GFAP) and calcifying lesions in the sub-cortex and cortex.

Authors:  Hidekazu Suzuki; Tomokatsu Yoshida; Mari Kitada; Juri Ichihashi; Hiroshi Sasayama; Yoshiro Nishikawa; Yoshiyuki Mistui; Masanori Nakagawa; Susumu Kusunoki
Journal:  J Neurol       Date:  2011-08-07       Impact factor: 4.849

Review 8.  Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.

Authors:  Julien Ratelade; A S Verkman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-17       Impact factor: 5.085

9.  Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis.

Authors:  Tomokatsu Yoshida; Masayuki Sasaki; Mari Yoshida; Michito Namekawa; Yuji Okamoto; Seiichi Tsujino; Hiroshi Sasayama; Ikuko Mizuta; Masanori Nakagawa
Journal:  J Neurol       Date:  2011-05-01       Impact factor: 4.849

10.  Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.

Authors:  Andrea Rossi; Julien Ratelade; Marios C Papadopoulos; Jeffrey L Bennett; A S Verkman
Journal:  Glia       Date:  2012-09-14       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.